Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nailner 2 in 1 + ciclopirox is a **topical combination treatment for nail fungal infections (onychomycosis)**. The product combines a cosmetic/medical solution (marketed as Nailner 2 in 1, primarily used to improve nail appearance and deliver antifungal ingredients) with **ciclopirox**, a broad-spectrum antifungal agent. Ciclopirox acts primarily by chelating polyvalent cations (such as Fe3+ and Al3+) in fungal cells, inhibiting metal-dependent enzymes crucial for fungal metabolism, notably the degradation of peroxides, which interrupts cellular processes essential for fungal survival[9]. The Nailner solution supports penetration and visible improvement, while ciclopirox provides targeted pharmacological antifungal action. The product is designed for direct application to nails and surrounding skin to treat mild to moderate fungal nail infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nailner 2 in 1 + ciclopirox.